register free | resend password

Pressemitteilungen zu dem Thema life sciences


Unterkategorien

PresseMitteilungen zu dem Schlagwort life sciences


Boundary Capital exits Image Scan to realise gain for investors

London, UK Boundary Capital has invested in a number of assets in technology and life sciences covering big data analytics, left science therapeutics and diagnostics, advanced manufacturing and security software. Image Scan Holdings plc has been a successful growth story. It has a range of different X-Ray products in the security and industrial market, notably portable X-Ray scanners for security in public places. Dan Somers, Managing Partner of Boundary Capital says: About Boundary Capita ...


05.02.2018

PAREXEL Launches Perceptive® Cloud for the Life Sciences Industry

Cloud Platform Built on Microsoft Azure Delivers PAREXEL BOSTON, December 12, 2017 Perceptive Cloud elevates PAREXEL Informatics solutions into an enhanced cloud infrastructure built on Microsoft Azure, combining PAREXEL Perceptive Cloud is designed to respond to the need within healthcare to deliver cost-effective innovation while trusting that sensitive information will stay secure across global environments. Introducing Perceptive Cloud represents the first milestone of the enterprise al ...


12.12.2017

Bioremediation Fungus Yields its Secrets

Vienna, 29. November 2017 – Thanks to genes acquired from bacteria, a fungus can degrade an environmentally harmful hydrocarbon - and comes under considerable stress in the process. These remarkable research findings, which were published recently, were obtained by a group from the University of Natural Resources and Life Sciences, Vienna (BOKU). The results were made possible thanks to the very latest equipment for genome and transcriptome analysis, the use of which is also open to third partie ...


29.11.2017

Aus and NZ oncologists can provide personalised cancer treatments using Caris Molecular Intelligence

Caris Life Sciences provides the most comprehensive genomic tumour profiling plus (CGP+) of DNA, RNA and proteins enabling personalised therapy decisions across immunotherapy, targeted therapy and chemotherapy. Since its foundation in 2008 Caris has collected clinical outcomes that show the superiority of CMI.1,2 Precision Oncology is proud to be the new exclusive distributor for Caris Molecular Intelligence in Australia and New Zealand. More than 6,000 oncologists from 58 countries have used ...


13.11.2017

Bioz, Inc. Announces the Addition of a New Algorithm to its Suite of Objective Star Ratings for Life Science Tools

PALO ALTO, CA -- (Marketwired) -- 09/07/17 -- , developers of the world''s first and most comprehensive search engine for life science experimentation, today announced immediate availability of the vendor rating system.Bioz vStars provides an average quality rating of a vendor''s products via a deep analysis that is based on hundreds of millions of life science products already mentioned in published scientific papers, while incorporating real-time usage data of more than o ...


07.09.2017

Investment Plan for Europe: EIB grants financing to Apeiron

Luxembourg, 28th August 2017 - The European Investment Bank (EIB) will provide financing of EUR 25 million to the Austrian biotech company Apeiron Biologics AG (Apeiron). The financing will support the development of new pharmaceutical products to treat cancer, particularly a rare type affecting children. The transaction with Apeiron was made possible by the support of the ''European Fund for Strategic Investments'' (EFSI). EFSI is the central pillar of the ''Invest ...


28.08.2017

Investment Plan for Europe: EIB grants financing to Apeiron

Luxembourg, 28th August 2017 - The European Investment Bank (EIB) will provide financing of EUR 25 million to the Austrian biotech company Apeiron Biologics AG (Apeiron). The financing will support the development of new pharmaceutical products to treat cancer, particularly a rare type affecting children. The transaction with Apeiron was made possible by the support of the 'European Fund for Strategic Investments' (EFSI). EFSI is the central pillar of the 'Investment Plan for Euro ...


28.08.2017

Bioz Launches Partner Program for Life Science Tool Vendors

PALO ALTO, CA -- (Marketwired) -- 06/20/17 -- , developers of the world''s first search engine for life science experimentation, today announced the formal launch of the Bioz Partner Program. The new program, aimed towards life science product vendors, provides a comprehensive set of vendor specific features and services and ultimately elevates vendor brand presence and product prominence at a time when researchers are actively making their purchasing decisions. Over thirty life scien ...


20.06.2017

Ovation Receives $1.5M in Funding and Launches Collaboration with iGeneTRAiN

CAMBRIDGE, MA -- (Marketwired) -- 05/24/17 -- (Ovation) announced today the receipt of 1.5 million dollars in funding from StageDotO, and existing investors, including Longfellow Ventures. The company will use the funds to continue the development of its next-generation scientific data-layer-as-a-service platforms, built to accelerate the progress of life science by improving how the story of scientific data is told. Ovation also announced a partnership with iGeneTRAiN to use Ovation Research ...


24.05.2017

Life Sciences and Medical Research Turn to Qumulo for Modern Scale-Out File Storage

SEATTLE, WA -- (Marketwired) -- 05/23/17 -- , the leader in modern scale-out storage, today announced that leading life sciences and medical research institutions are choosing Qumulo to accelerate their data-intensive workflows, including cancer and infectious disease research, genomics, bioinformatics, proteomics, microscopy and big data. Johns Hopkins Genomics (including the NIH ), the Center for Infectious Disease Research, Georgia Cancer Center at Augusta University, Channing Division of Ne ...


23.05.2017

BioTeam Test Lab at Texas Advanced Computing Center Deploys Avere Systems

PITTSBURGH, PA -- (Marketwired) -- 05/18/17 -- , a leading provider of hybrid cloud enablement solutions, announced today that is incorporating Avere FXT Edge filers into its Convergence Lab, a testing environment hosted at the Texas Advanced Computing Center (TACC), in Austin, Texas. In cooperation with vendors and TACC, BioTeam utilizes the lab to evaluate solutions for its clients by standing up, configuring and testing new infrastructure under conditions relevant to life sciences in order ...


18.05.2017

Cora Systems Presents Keynote Speaker at the Medical Device Project & Portfolio Management Conference

ARLINGTON, VA -- (Marketwired) -- 05/09/17 -- , a leading global provider of enterprise portfolio, program and project management (EPPM) solutions, is presenting John McGrath as a keynote speaker at the marcus evans May 17 and 18 at the Embassy Suites in St. Paul, MN.As a PMO Consultant and Project Management Lecturer at the Dublin Institute of Technology, Dr. McGrath will deliver a presentation on May 18 at 11:45 a.m. that includes how to move portfolio management to an operations setting vs. ...


09.05.2017

Phoenix Life Sciences, Inc. Appoints James Baumgartner as New CEO

DENVER, CO -- (Marketwired) -- 05/04/17 -- Phoenix Life Sciences, Inc. ("Phoenix Life"), a disruptive healthcare solutions company and biotech innovator, is pleased to announce that it has appointed James "Jamie" Baumgartner as Chief Executive Officer. Baumgartner''s selection concludes Phoenix Life''s exhaustive national search for a qualified CEO to lead the company to its next stage in growth."I''m honored to be appointed as the CEO for ...


04.05.2017

Tiziana Life Sciences PLC: Exercise of Warrants & Issue of Equity

LONDON, UNITED KINGDOM -- (Marketwired) -- 03/24/17 -- Tiziana Life Sciences PLC (AIM: TILS)AIM: TILS- Tiziana Life Sciences plc (AIM: TILS, the "Company"), the clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, announces that it has received a notification from warrant holders to exercise warrants over 1,789,524 ordinary shares in the Company at an exercise price of 32p per share, providing the Company with gross proceeds of £ ...


24.03.2017

Sri Lankan patients to receive safer and more available medications with new DHL Life Sciences facility

COLOMBO, SRI LANKA -- (Marketwired) -- 03/16/17 -- Global Forwarding, the leading international provider of air, sea and road freight services, today launched the first-of-its-kind Life Sciences facility in Colombo designed to ensure world-class product safety and availability for Sri Lanka''s drug manufacturers and importers.With automated temperature monitors covering its entire campus including a cool-room chilled to 2-8 degrees C, the new facility offers Sri Lankan pharmaceutical ...


17.03.2017

Bioz Launches Next-Generation of Industry''s First and Only Search Engine for Life Science Experimentation

PALO ALTO, CA -- (Marketwired) -- 03/07/17 -- , developers of the world''s first search engine for life science experimentation, today launched the next-generation of its patent-pending search engine platform. The updated cloud technology includes a new user interface, extensive coverage of scientific articles, a new vendor partner program, and a new level of quality and accuracy of search results, while also offering deep insights on how to best use life science products in experimen ...


07.03.2017

RepliCel Life Sciences Announces Re-pricing of Warrants

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 03/06/17 -- RepliCel Life Sciences Inc. ("RepliCel" or the "Company") (OTCQB: REPCD)(TSX VENTURE: RP)(FRANKFURT: P6P2), a clinical stage regenerative medicine company focused on the development of autologous cell therapies, announces that it has applied to the TSX Venture Exchange (the "Exchange") for an amendment to the exercise price of 148,226 non-transferable share purchase warrants (the "April Warrants" ...


07.03.2017

Phoenix Life Sciences to Acquire Phoenix Bio Pharmaceuticals

DENVER, CO -- (Marketwired) -- 01/31/17 -- ("Phoenix Life"), a disruptive healthcare solutions company and biotech innovator, is pleased to announce that a Letter of Intent has been executed for the acquisition of Phoenix Bio Pharmaceuticals Corporation. Phoenix Bio Pharmaceuticals is a privately held company with a focus on intellectual property ("IP"). The current IP portfolio consists of condition-specific formulations, multiple proprietary compounds, extraction technolo ...


31.01.2017

Trelleborg Advances Contract Manufacturing Services for Drug-Device Combination Products

ANAHEIM, CA and FORT WAYNE, IN -- (Marketwired) -- 01/24/17 -- At Booth 1605, will highlight its contract manufacturing services for delivering drug-device components, which enable the combination of components in any two or three product categories: medical devices, drugs and/or biologics. These capabilities leverage deep engineering experience and pharmaceutical licensing to provide complete start to finish product development and manufacturing for drug-eluting medical devices, which are de ...


24.01.2017

Phoenix Life Sciences Appoints NMS Capital Advisors, LLC to Act as the Company''s Exclusive Financial Advisor

DENVER, CO -- (Marketwired) -- 01/13/17 -- Phoenix Life Sciences, Inc. (Phoenix), a disruptive healthcare solutions company, is pleased to announce the appointment of NMS Capital Advisors, LLC ("NMS"), a leading global investment bank and registered broker dealer headquartered in Beverly Hills, California, to act as the Company''s exclusive financial advisor banker and lead placement agent. NMS shall advise the Company on its current plans involving industry repositioning, e ...


13.01.2017

L.E.K. Consulting Announces 12 Global Partner Promotions

CHICAGO, IL -- (Marketwired) -- 01/09/17 -- L.E.K. Consulting, a global management consulting firm, has announced the promotion of 12 new partners. The new partners have all advanced within L.E.K. and strengthen the expertise the firm brings to bear for clients across multiple and ."I am delighted to announce our newest L.E.K. partners and recognize all they have accomplished in delivering exceptional results and impact for our clients," said , global managing partner. "We congr ...


09.01.2017

RepliCel CEO Provides 2017 Forecast

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/05/17 -- RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX VENTURE: RP) ("RepliCel" or the "Company"), a clinical-stage regenerative medicine company developing unique biologic products to revolutionize pattern baldness and thinning hair treatment, reverse the effects of aging and sun-damaged skin, and repair chronic tendon degeneration, is pleased to provide an update to shareholders from its President and CEO, Mr. R. Lee Bu ...


05.01.2017

2017 Biotech Predictions Foretell Race Towards Cloud, e-Commerce and Greater Transparency

PALO ALTO, CA -- (Marketwired) -- 12/13/16 -- , developers of the world''s first search engine for life science experimentation, today highlighted six predictions for how the biotechnology industry will make strides in 2017 to advance health and drug discovery.Bioz predicts that 2017 is the year biotech truly will catch up in terms of adopting new trending and emerging technologies in order to accelerate life science research and ultimately save lives. Not only does this include embra ...


13.12.2016

Trelleborg Named 2016 Kinetic Process Innovation Award Winner for Advanced Seal Engineering

FORT WAYNE, IN -- (Marketwired) -- 12/06/16 -- , a world leader in engineered polymer solutions, has received recognition by the Kinetic Process Innovation Awards program for its significant contribution in advanced seal engineering and innovation in the healthcare and medical device industry, more specifically in the advancement of intelligent surgical instruments.Sponsored by , the panel of judges has selected Trelleborg for this award due to its demonstration of excellence in supporting the ...


06.12.2016

Fish & Richardson Announces Six Principals Named 2016 "Life Science Stars" by LMG Life Sciences

BOSTON, MA -- (Marketwired) -- 11/21/16 -- announced today that six of its principals -- , , , , , and -- were named "Life Science Stars" for 2016 in the fifth annual edition of . One client noted that Fish attorneys possess "exceptional skills as patent litigation trial counsel" and "get the importance of being a good partner."The firm''s Life Sciences practice also received top rankings. Fish was "Highly Recommended" for Patent Prosecution, ...


21.11.2016

Galileo Life Sciences, Inc. files application with OTC Markets

TORONTO, ON -- (Marketwired) -- 11/09/16 -- Galileo Life Sciences, Inc. ("the Company") (OTC PINK: MDRM) announced today that it has filed an application with the OTC Markets to have the yield notice removed from its trading symbol. This is the first of several steps that the Company is now taking to get its filings up to date and get back in compliance with the rules governing a fully reporting public company, including making its late periodic filings under the Securities Exchange A ...


09.11.2016

Quanticate Names Alan Morgan Chief Operating Officer

LONDON, UNITED KINGDOM and RESEARCH TRIANGLE PARK, NC -- (Marketwired) -- 10/04/16 -- , a leading global data-focused (CRO) today announced that it has named Alan Morgan as the company''s Chief Operating Officer. Reporting to Quanticate''s Chairman and Chief Executive Officer David Underwood, Morgan will work across Quanticate''s global office network (UK, US, India, South Africa, and Poland) to build and expand upon the company''s reputation for outstan ...


04.10.2016

Tiziana Life Sciences PLC Announces Interim Results for the Six Months Ended 30 June 2016

LONDON, UNTIED KINGDOM -- (Marketwired) -- 09/29/16 -- Tiziana Life Sciences plc (AIM: TILS)(AIM: TILS)("Tiziana" or "the Company")London, 29 September 2016 - Tiziana Life Sciences plc ("Tiziana", AIM: TILS), the research and clinical stage biotechnology company focussing on proprietary drug candidates to treat cancer and autoimmune diseases, today announces its interim results for the six months ended 30 June 2016.Highlights during the period:The Company significa ...


29.09.2016

RepliCel Announces Debt Settlement

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/27/16 -- RepliCel Life Sciences Inc. (OTCQB: REPCD)(TSX VENTURE: RP)(FRANKFURT: P6P2) ("RepliCel" or the "Company"), a clinical-stage regenerative medicine company focused on the development of autologous cell therapies, is pleased to announce its intention to settle debt (the "Debt Settlement") in the aggregate amount of $374,071.63 owed by the Company to certain creditors by the issuance of 719,368 units (each, ...


27.09.2016

Tiziana Life Sciences PLC: Confirmation of Capital Reduction

LONDON, UNITED KINGDOM -- (Marketwired) -- 09/15/16 -- Tiziana Life Sciences plc (AIM: TILS)("Tiziana" or the "Company")London, 15 September 2016 - Tiziana Life Sciences plc (AIM: TILS), a clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, today announces, further to its announcement dated 30 June 2016 the High Court made an Order on 14 September 2016 ("Order") confirming the capital reduction approved by sh ...


15.09.2016

Questex Appoints Francis Barker, Veteran Finance Executive, as CFO

NEWTON, MA -- (Marketwired) -- 09/06/16 -- , a leading global business information and events company, today announced the appointment of Francis B. Barker, a veteran finance executive, as chief financial officer, responsible for leading the company''s financial operations, human resources and enterprise technology.Reporting to Kerry C. Gumas, Questex president and chief executive officer, Barker will be based in New York."Francis brings to Questex over two decades of experience ...


06.09.2016

Tiziana Life Sciences PLC: Change of Registered Office

LONDON, UNITED KINGDOM -- (Marketwired) -- 08/18/16 -- Tiziana Life Sciences plc (AIM: TILS)AIM: TILSLondon, 18 August 2016 - Tiziana Life Sciences plc (AIM: TILS), a clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, today announces that its registered office address has changed to: 3rd Floor 11-12 St. James''s Square, London, United Kingdom, SW1Y 4LB.Tiziana Life Sciences plc is a UK biotechnology company that focuses on the ...


18.08.2016

Questex to Launch FierceBiotech Drug Development Forum in Boston

NEWTON, MA -- (Marketwired) -- 08/15/16 -- , a leading global business information and events company, today announced the debut of , which will bring together leading pharmaceutical and biotech professionals for an exclusive discussion about the latest challenges, trends and innovations in drug discovery, research and development.The inaugural event, to be held Sept. 19-21 at the InterContinental Boston, is expected to draw more than 250 industry participants including more than 85 speakers, s ...


15.08.2016

RepliCel Life Sciences Announces Completion of the Final Injection in Its Tendon Repair Clinical Trial

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 08/11/16 -- RepliCel Life Sciences Inc. ("RepliCel" or the "Company") (OTCQB: REPCF) (TSX VENTURE: RP) (FRANKFURT: P6P1), a clinical stage regenerative medicine company focused on the development of autologous cell therapies, announced today that it has performed the final injection in its clinical trial of RCT-01 treating patients with chronic achilles tendinopathy. The last scheduled patient visit to collect treatment follo ...


11.08.2016

RepliCel Life Sciences Share Consolidation Approved

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 08/09/16 -- RepliCel Life Sciences Inc. ("RepliCel" or the "Company") (OTCQB: REPCF)(TSX VENTURE: RP) (FRANKFURT: P6P1), a clinical stage regenerative medicine company focused on the development of autologous cell therapies, announced today that, further to its News Release of July 22, 2016, the TSX Venture Exchange has approved the consolidation of the common shares of the Company (each, a "Share") on the basis of t ...


09.08.2016

RepliCel Life Sciences Continues Restructuring With Share Structure Consolidation

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/22/16 -- RepliCel Life Sciences Inc. ("RepliCel" or the "Company") (OTCQB: REPCF)(TSX VENTURE: RP) (FRANKFURT: P6P1), a clinical stage regenerative medicine company focused on the development of autologous cell therapies, announced today that its Board of Directors has authorized a plan to proceed with a consolidation of its outstanding common shares (each, a "Share") on the basis of ten (10) pre-consolidation Sha ...


22.07.2016

RepliCel''s Cell Therapy for Pattern Baldness Proceeds to Clinical Trial Launch in Japan

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/21/16 -- RepliCel Life Sciences Inc. (OTCQB: REPCF)(TSX VENTURE: RP)(FRANKFURT: P6P1), ("RepliCel" or the "Company"), a clinical-stage regenerative medicine company focused on the development of autologous cell therapies, is pleased that its RCH-01 product, for the treatment of androgenetic alopecia, is now cleared by the Japanese regulatory authorities for use in a clinical research study launching now in Japan.The study, ...


21.07.2016

Tiziana Acquires a Unique Bio-Repository From Shardna SpA and Establishes LonGevia Genomics Srl, a Sardinian Based Subsidiary to Further Enhance and Develop Its Portfolio

LONDON, UNITED KINGDOM -- (Marketwired) -- 07/18/16 -- Tiziana Life Sciences PLC (AIM: TILS)AIM: TILS- Tiziana Life Sciences plc (AIM: TILS), a clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, announces today that it has purchased key assets from Shardna SpA ("Shardna") a biobanking and genomics research company located in Cagliari, Sardinia, for a total value of EUR 258,000. Tiziana has also established an Italian subsidiary ...


18.07.2016

Questex Acquires ExL Events

NEWTON, MA -- (Marketwired) -- 07/11/16 -- , a leading global business information and events company, today announced it has acquired Inc., expanding its presence in the global pharmaceutical, life-science and health-care markets.ExL Events, founded in 2004 as ExL Pharma, is the industry leader in developing innovative, educational conferences that serve the pharmaceutical, life-science and health-care communities. Kerry Gumas, Questex president and chief executive officer, said ExL will comp ...


11.07.2016

Tiziana Life Sciences PLC: Result of AGM

LONDON, UNITED KINGDOM -- (Marketwired) -- 06/30/16 -- Tiziana Life Sciences PLC (AIM: TILS)AIM: TILSLondon, 30 June 2016 - Tiziana Life Sciences plc (AIM: TILS), a clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, announces that at the AGM held today, all resolutions proposed at the meeting were duly passed.Pursuant to the terms of the deferred share buyback approved by Resolution 8 at the AGM, the Company has issued one ordinary share ...


30.06.2016

Tiziana Life Sciences PLC Announces Exercise of Warrants, Conversion of Convertible Loan Notes and Issue of Equity

LONDON, UNITED KINGDOM -- (Marketwired) -- 06/29/16 -- Tiziana Life Sciences PLC (AIM: TILS)AIM: TILSLondon, 29 June 2016 - Tiziana Life Sciences plc (AIM: TILS), a clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, announces that it has received the following notifications:(i) from warrant holders to exercise warrants over 206,250 ordinary shares in the Company at an exercise price of 32p per share, providing the Company with gross proc ...


29.06.2016

Oracle Announces Pfizer''s Selection of Oracle Cloud for Clinical Data Management and Trial Management Across Its Clinical Trial Portfolio

REDWOOD SHORES, CA -- (Marketwired) -- 06/20/16 -- Oracle today announced that after a detailed review and selection process, Pfizer has selected Oracle Health Sciences InForm Cloud Service and the Oracle Siebel Clinical Trial Management and Monitoring Cloud Service to help manage and monitor its more than 300 clinical trials a year and continue to provide best-in-class solutions."Oracle Health Sciences InForm Cloud Service and Oracle Siebel Clinical Trial Management and Monitoring Cloud S ...


20.06.2016

SHYFT Analytics Appoints Priya Sapra to Chief Product Officer

WALTHAM, MA -- (Marketwired) -- 06/07/16 -- , a leader in cloud-based data and analytics solutions for the global life sciences industry, today announced senior leader Priya Sapra has been named Chief Product Officer. As a veteran of the analytics industry and the former Vice President of Analytics at SHYFT, Sapra will own, design, and implement the company''s vision for products derived from the SHYFT Enterprise Platform. She will continue to interface with customers to address their ...


07.06.2016

Tiziana Life Sciences PLC: Final Results for the year ended 31 December 2015

LONDON, UNITED KINGDOM -- (Marketwired) -- 06/07/16 -- Tiziana Life Sciences PLC (AIM: TILS)AIM: TILS- Tiziana Life Sciences plc (AIM: TILS), a clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, today announces its Final Results for the year ended 31 December 2015.Highlights during the period:£ 12.8m (gross) raised through placing of shares and convertible loan notesLicensed milciclib, which is currently in phase II clinical trials for t ...


07.06.2016

Tiziana Partnership with Cardiff Researchers Wins Innovation in Healthcare Award

LONDON, UNITED KINGDOM -- (Marketwired) -- 06/01/16 -- Tiziana Life Sciences PLC (AIM: TILS)AIM: TILS- Tiziana Life Sciences plc (AIM: TILS), a clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, today notes that Cardiff University has announced that the partnership between Tiziana Life Sciences and researchers at Cardiff University, which has led to the development of a potential new drug for metastatic breast cancer, has won the Innovat ...


01.06.2016

Immunotherapy Journal Review of Anti - CD3 Monoclonal Antibodies Highlights Therapeutic Potential of Tiziana''s Foralumab

LONDON, UNITED KINGDOM -- (Marketwired) -- 05/19/16 -- Tiziana Life Sciences plc (AIM: TILS)- Tiziana Life Sciences plc (AIM: TILS), a clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, today announced that foralumab, was featured in a review article entitled, "Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside" published online ahead of print in peer-reviewed journal, Immunotherapy (see ). This follows the annou ...


19.05.2016

Tiziana Life Sciences PLC: Appointment of Dr. Robert Evans

LONDON, UNITED KINGDOM -- (Marketwired) -- 05/04/16 -- Tiziana Life Sciences PLC (AIM: TILS)AIM: TILSLondon, 04 May 2016 - Tiziana Life Sciences plc (AIM: TILS, the "Company"), the clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, today announces that it has further expanded its clinical development team with the key appointment of Robert Evans, PharmD. as Vice President of Clinical Sciences. Dr. Evans will report to James Tri ...


04.05.2016

RepliCel Life Sciences Extends Warrant Expiry Dates and Amends Warrant Exercise Price

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/29/16 -- RepliCel Life Sciences Inc. ("RepliCel" or the "Company") (OTCQB: REPCF)(TSX VENTURE: RP), a clinical stage regenerative medicine company focused on the development of autologous cell therapies, announced today approval by the TSX Venture Exchange (the "TSXV") to extend the term of 3,765,834 share purchase warrants (the "Extended Warrants").The Company approved the closing of a private placement ...


29.04.2016

Tiziana Life Sciences PLC Announces Exercise of Warrants & Issue of Equity

LONDON, UNITED KINGDOM -- (Marketwired) -- 04/28/16 -- Tiziana Life Sciences PLC (AIM: TILS)AIM: TILSExercise of Warrants & Issue of EquityLondon, 28 April 2016 - Tiziana Life Sciences plc (AIM: TILS, the "Company"), the clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, announces that it has received a notification from warrant holders to exercise warrants over 1,095,000 ordinary shares in the Company at an exercise price ...


28.04.2016

RepliCel Life Sciences Conducts Formal Consultation Review With Japan''s PMDA and Receives Unprecedented Review Fee Reduction

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/25/16 -- RepliCel Life Sciences Inc. (OTCQB: REPCF)(TSX VENTURE: RP)(FRANKFURT: P6P1), a clinical stage regenerative medicine company focused on the development of autologous cell therapies, announced that it met this month with Japan''s Pharmaceuticals and Medical Devices Agency (PMDA) in Tokyo. The meeting was a formal consultation review of the company''s pre-clinical, quality, and manufacturing data related to its non-b ...


25.04.2016

RepliCel Life Sciences Finishes Enrolment for its Tendon Repair and Skin Rejuvenation Clinical Trials

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/20/16 -- RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX VENTURE: RP) (FRANKFURT: P6P1), a clinical stage regenerative medicine company focused on the development of autologous cell therapies, announced today that it has enrolled its final patients for both its RCT-01 and RCS-01 clinical trials. This ensures clinical data for both trials will be analyzed and released near year-end. Positive safety data will allow the company to move forward wit ...


20.04.2016

How clean is your drinking water supply at home?

January 2016 saw the official launch of a new website for domestic consumer water testing services in Ireland – www.alswatertesting.ie The website was developed to meet growing Irish consumer demand for a service to test the water quality of public domestic water supplies as well as for those with private water wells. Speaking at the launch event at the ALS Life Sciences headquarters in Clonmel, managing director Jeff Carroll said: “Clean drinking water is important to everybody’s health and ...


13.04.2016

RepliCel Life Sciences Applies to Amend Warrant Exercise Price and Extend Warrant Expiry Dates

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/08/16 -- RepliCel Life Sciences Inc. ("RepliCel" or the "Company") (OTCQB: REPCF) (TSX VENTURE: RP), a clinical stage regenerative medicine company focused on the development of autologous cell therapies, announced today that it has applied to the TSX Venture Exchange (the "TSXV") to extend the term of 2,043,555 share purchase warrants (the "Warrants"). The original term of 1,643,555 of the Warrants was ...


08.04.2016

Silicon Mechanics Announces Recipients of 5th Annual Research Cluster Grant

BOTHELL, WA -- (Marketwired) -- 04/06/16 -- Silicon Mechanics, a leading provider of servers, storage and high-performance computing solutions to the world''s most innovative organizations, today announced the recipients of its fifth annual : the University of New Orleans and the University of California, Merced. Each grant awardee will receive a High-Performance Computing (HPC) cluster with the latest high-performance processing and GPU technologies, valued at over $100,000 for use i ...


06.04.2016

RepliCel Life Sciences Announces Restructuring, Cost Reductions and Closing of Private Placement

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/06/16 -- RepliCel Life Sciences Inc. ("RepliCel" or the "Company") (OTCQB: REPCF) (TSX VENTURE: RP), a clinical stage regenerative medicine company focused on the development of autologous cell therapies, announced today that its Board of Directors has authorized a plan to downsize all non-critical programs and staff in an effort to preserve capital to focus on the following three essential priorities pending a major financ ...


06.04.2016

Trelleborg Sealing Solutions Appoints President of Marketing Americas

FORT WAYNE, IN and SCHAUMBERG, IL -- (Marketwired) -- 04/05/16 -- the leading global developer, manufacturer and supplier of precision seals and bearings, appoints Linda Muroski, President of Marketing Americas, headquartered in Fort Wayne, Indiana.Muroski joins Trelleborg Sealing Solutions from BASF where she held several leadership roles starting in 2000 and most recently served as the Director of Water Solutions, North America. With extensive sales and management experience, Muroski has suc ...


05.04.2016

Tiziana Life Sciences plc Tiziano Lazzaretti Appointed as Chief Financial Officer

LONDON, UNITED KINGDOM -- (Marketwired) -- 04/04/16 -- Tiziana Life Sciences plc (AIM: TILS)("Tiziana" or "the Company")London, 4 April 2016 - Tiziana Life Sciences plc (AIM: TILS, the "Company"), the clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, today announces that it has appointed Tiziano Lazzaretti as Chief Financial Officer, effective immediately. Mr Lazzaretti''s appointment is not to th ...


04.04.2016

Vaisala Deploys Qumulo Data-Aware Scale-Out NAS for Next-Generation Insight Into Large Scale Machine Data

SEATTLE, WA -- (Marketwired) -- 03/29/16 -- , the leader in data-aware scale-out NAS, today announced that , a global leader in environmental and industrial measurement, has selected to stay ahead of the growing volume, variety and velocity of environmental sensor and modeling data.Vaisala is a global leader in environmental and industrial measurement products and services. With a mission to ensure reliable environmental observations for better decision making, the company works to increase th ...


29.03.2016

Fish & Richardson Sweeps Managing Intellectual Property''s Tier 1 National IP Rankings for Sixth Consecutive Year

BOSTON, MA -- (Marketwired) -- 03/25/16 -- has received Tier 1 IP rankings in every national category -- Patent Prosecution, Patent Litigation, Bio/Life Sciences, PTAB Litigation, and ITC -- in Managing Intellectual Property (MIP) magazine''s annual ranking of the top IP law firms in the U.S. This is the sixth year in a row that Fish has swept the Tier 1 national U.S. rankings. According to MIP, "The top-tier firms possess an outstanding reputation in their jurisdiction and boas ...


25.03.2016

Choate, Hall & Stewart''s Intellectual Property Group Receives Top Rankings From Managing Intellectual Property

BOSTON, MA -- (Marketwired) -- 03/11/16 -- announced today that it received top national rankings in bio/life sciences, patent prosecution, and patent litigation from Managing Intellectual Property (MIP). The firm was also "Highly Recommended" in Massachusetts, which is the highest ranking a firm can attain. According to MIP, firms that are included in the rankings have been recognized by "competitors and/or clients...as one of the most capable, active firms in IP" in their ...


11.03.2016

Choate, Hall & Stewart LLP Announces New Practice Group Leaders

BOSTON, MA -- (Marketwired) -- 03/09/16 -- today announced that has been named co-chair of the firm''s Business Technology Group and has been appointed co-chair of its Finance & Restructuring Group.Pitfield, who is a member of the firm''s Hiring Committee, will serve as co-chair of the Business Technology Group with current co-chair Brian Goldstein. The highly regarded group includes attorneys with expertise in life sciences and technology, venture capital, mergers an ...


09.03.2016

Unissant Adds Four Additional CIO-SP3 Task Areas

RESTON, VA -- (Marketwired) -- 02/22/16 -- Unissant, one of the region''s noted providers of advanced data analytics, today announced it has been qualified to bid on four additional CIO-SP3 task areas. Now the company is eligible for contract awards all 10 CIO-SP3 task areas.The Chief Information Officer-Solutions and Partners III (CIO-SP3) contract is administered by the National Institutes of Health Information Technology Acquisition and Assessment Center (NITAAC) -- part of the Dep ...


22.02.2016

Bridge Bank Life Sciences Group Hires Justin McDonie to Lead Its Midwest and East Coast Business Development Efforts

DURHAM, NC -- (Marketwired) -- 02/17/16 -- Bridge Bank today announced the recent hiring of seasoned lender, Justin McDonie as senior vice president and managing director responsible for the Midwest and East Coast business development activities for its Life Sciences Group. Justin will be based out of Durham, North Carolina."We are extremely excited to have Justin on the team and are confident his wealth of experience and industry knowledge will make a significant impact on the Midwest and ...


17.02.2016

RepliCel Announces CEO Update

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 02/16/16 -- RepliCel Life Sciences Inc. (OTCQB: REPCF)(TSX VENTURE: RP) ("RepliCel" or the "Company"), a clinical-stage regenerative medicine company focused on the development of autologous cell therapies, is pleased to provide an update to shareholders from its new President and CEO, Mr. R. Lee Buckler.Dear Shareholders,In my initial communication to you as RepliCel''s CEO, I want to convey what we look to accompli ...


16.02.2016

Trelleborg Sealing Solutions Announces Enhanced Digital Tools and Services to Support Life Sciences Applications

ANAHEIM, CA -- (Marketwired) -- 02/09/16 -- will showcase its newest collection of online tools and sealing resources for life sciences and medical device professionals at . The are based on 50 years of engineering expertise and knowledge and are designed to educate, inform and guide engineers to meet their product design requirements.Medical device and life sciences engineers can now benefit from gaining a better understanding of terminology and guidance to select the right compatible materi ...


09.02.2016

Unissant Names Jango Unwalla Chief Marketing Officer

RESTON, VA -- (Marketwired) -- 02/09/16 -- Unissant, one of the region''s noted providers of advanced data analytics, has appointed Jango Unwalla as Chief Marketing Officer, a new position for the company. Previously Senior Vice President of Corporate Development, Unwalla will continue to focus on business development, with additional responsibility for industry and corporate marketing. He will oversee market research, pricing, branding and communications, and partner management. Unwa ...


09.02.2016

Tiziana Life Sciences PLC ("Tiziana" or the "Company") Fund Raising

LONDON, UNITED KINGDOM -- (Marketwired) -- 01/13/16 -- Tiziana Life Sciences plc (AIM: TILS) (the ""), the clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, is pleased to announce that it has raised £ 709,406 (US$1,021,523) through the issue of 472,938 unsecured convertible loan notes ("") to certain existing investors ("").Funds raised by the issue of the CLNs will be used to fund the development of the Co ...


13.01.2016

RepliCel Receives European Patent for its Innovative Dermal Injector Technology

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/11/16 -- RepliCel Life Sciences Inc. (OTCQB: REPCF)(TSX VENTURE: RP), a clinical stage regenerative medicine company focused on the development of autologous cell therapies, today announced that it has been granted a patent (EP2623146) by the European Patent Office for its injection device technologies. The first device being developed under this patent, RCI-02, is designed for injecting hyaluronic acid as a dermal filler. The device is also b ...


11.01.2016

Unissant Names Beth Hiatt Chief Operating Officer

RESTON, VA -- (Marketwired) -- 01/11/16 -- Unissant, one of the region''s noted providers of advanced data analytics, has promoted Beth Hiatt to Chief Operating Officer. Previously Executive Vice President, Operations and Delivery, Hiatt will continue to oversee client delivery, with additional responsibility for the company''s overall business and financial performance objectives. These include revenue growth, profitability, program performance, customer satisfaction, techn ...


11.01.2016

Tiziana Life Sciences PLC: Tiziana Life Sciences PLC Announces Development Plans for Foralumab & SAB Appointments

LONDON, UNITED KINGDOM -- (Marketwired) -- 01/11/16 -- Tiziana Life Sciences plc (AIM: TILS)| AIM: TILS- Tiziana Life Sciences plc (AIM: TILS, the "Company"), a clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, today announced its plan for further development of foralumab, the company''s fully human anti-CD3 antibody, along with the addition of two key members: Professors Kevan Herold, MD and Howard Weiner, MD who wi ...


11.01.2016

Update on Tiziana''s Bcl-3 Inhibitor

LONDON, UNITED KINGDOM -- (Marketwired) -- 01/08/16 -- Tiziana Life Sciences PLC (AIM: TILS)| AIM: TILS- Tiziana Life Sciences plc (AIM: TILS, the "Company"), a clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, announced today that its research agreement with Cardiff University, focused on pioneering the development of Bcl-3 inhibitors as potential drugs to treat cancer, has led to the identification of a first-in-class lead c ...


08.01.2016

Healthcare Cloud Analytics Company SHYFT Doubles Customers and Employees in 2015

WALTHAM, MA -- (Marketwired) -- 12/21/15 -- In less than 20 months after raising its first round of growth capital, , a leader in cloud data management and guided analytics for global life sciences, has grown to over 100 employees and more than doubled the number of Life Sciences customers as it closes out a breakout year. Marked by a 100 percent increase in software subscriptions, new customers include both large pharma companies as well as emerging biotech firms. The SaaS-based company'& ...


21.12.2015

RepliCel Announces Completion of First Injections in Clinical Trial of RCS-01 for Skin Aging and UV-Damaged Skin

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/17/15 -- RepliCel Life Sciences Inc. (OTCQB: REPCF)(TSX VENTURE: RP), a clinical stage regenerative medicine company focused on the development of autologous cell therapies, today announced that the first injections of study products have been completed in the phase 1 clinical study () evaluating RCS-01, an autologous cell-based skin rejuvenation product. RepliCel is developing RCS-01 as a longer-lasting, more natural alternative to existing de ...


17.12.2015

Fish & Richardson Principal Jonathan Singer Named 2015 Life Sciences MVP by Law360

MINNEAPOLIS, MN -- (Marketwired) -- 12/01/15 -- today announced that principal , head of the firm''s Life Sciences Practice, has been named a 2015 "Life Sciences MVP" by Law360. According to Law360, Singer is among "those elite attorneys whose successes in high-stakes litigation, record-breaking deals and complex global matters earned them a spot on this year''s list of MVP award winners." This was the second time in three years that Singer made Law360&# ...


01.12.2015

Fish & Richardson Announces Five Principals Named 2015 "Life Science Stars" by LMG Life Sciences

BOSTON, MA -- (Marketwired) -- 11/10/15 -- announced today that five of its principals -- , , , and -- were named intellectual property (IP) "Life Science Stars" for 2015 in the fourth annual edition of LMG Life Sciences. The firm''s Life Sciences practice also received top rankings, with the publication noting "Fish & Richardson is consistently praised for their expertise in all matters of IP representation."Fish was "Highly Recommended" for Paten ...


10.11.2015

Joseph Lamendola, Ph.D. Joins YourEncore Regulatory Practice as Senior Vice President

INDIANAPOLIS, IN -- (Marketwired) -- 11/10/15 -- YourEncore (), a company that helps firms in the , and industries solve complex innovation, compliance and productivity challenges announced that Joseph Lamendola, Ph.D., has joined the company as senior vice president of the company''s Regulatory Practice.YourEncore launched the earlier this year, bringing together a group of high-profile pharmaceutical, consumer packaged goods (CPG) and FDA executives and opinion leaders with deep ...


10.11.2015

Unissant to Provide SharePoint Support Services to Navy Medicine Training Support Center

SAN ANTONIO, TX -- (Marketwired) -- 11/09/15 -- Unissant, one of the nation''s fastest growing providers of information management, business solutions, and data analytics services, announced today it has been selected by the Navy Medicine Training Support Center (NMTSC) to provide MS SharePoint services for the Medical Education and Training Campus (METC).NMTSC supports the Department of Defense as the Navy component command providing administrative and operational control over Navy s ...


09.11.2015

ProMetic Announces the Appointment of Its New Chief Financial Officer

LAVAL, QUEBEC -- (Marketwired) -- 11/02/15 -- ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("ProMetic" or the "Corporation") is pleased to announce the appointment of Mr. Gregory Weaver, as its Chief Financial Officer. This announcement follows the promotion of Mr. Bruce Pritchard to the position of Chief Operating Officer, announced earlier in August 2014. Mr. Pritchard had, in the interim, continued to act as CFO for ProMetic.Mr. Weaver is a senior finance profes ...


02.11.2015

ProMetic''s PBI-4050 Cleared to Commence Clinical Trial in Patients With Type 2 Diabetes and Multi-Organ Fibrosis in Europe

LAVAL, QUEBEC -- (Marketwired) -- 10/29/15 -- ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF), ("ProMetic" or the "Corporation") announced today that the clinical trial application ("CTA") for its anti-fibrotic lead drug candidate PBI-4050 in patients suffering from a condition associated with type 2 diabetes and severe multi-organ fibrosis has been cleared by the Medicines and Healthcare Products Regulatory Agency ("MHRA") in the United Kingdom.PBI ...


29.10.2015

Unissant Names David P. Dougherty Chief Growth Officer and Executive Vice President

RESTON, VA -- (Marketwired) -- 10/27/15 -- Unissant, Inc., one of the region''s leading providers of software, data analytics, and business transformation services to the federal marketplace, has named David P. Dougherty as the company''s first Chief Growth Officer and Executive Vice President of Business Development. In this capacity, he will oversee business development and growth strategies across all of the company''s markets. Dougherty will report to Unissant& ...


27.10.2015

ProMetic''s IVIG IND Cleared by FDA

LAVAL, QUEBEC -- (Marketwired) -- 10/26/15 -- ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF) ("ProMetic" or the "Corporation") announced today that the US Food and Drug Administration ("FDA") has completed its review and has cleared the Investigational New Drug ("IND") application for ProMetic''s IVIG for the treatment of primary immunodeficiency diseases ("PIDD")."We are pleased to have received regulatory clearance for ou ...


26.10.2015

Galileo Life Sciences (MDRM) Appoints New Vice President of Corporate Development Glenn Vengroff

TORONTO, ON -- (Marketwired) -- 10/21/15 -- . (''the Company") (OTC PINK: MDRM) announces that Glenn Vengroff has joined the company as Vice President, Corporate Development. Glenn is formerly Executive Vice President of an equity consulting firm in Toronto, Ontario, specializing in assisting early stage micro-cap to small-cap private companies to raise growth capital. Glenn played a key role in the successful launch of several publicly traded companies, initiated Investor awaren ...


22.10.2015

Dr. Brenda Herschbach Jarrell From Choate, Hall & Stewart Named 2015 "Top Woman of Law" by Massachusetts Lawyers Weekly

BOSTON, MA -- (Marketwired) -- 10/20/15 -- announced today that , co-chair of the firm''s Life Sciences and Intellectual Property Groups, has been named a "Top Woman of Law" by Massachusetts Lawyers Weekly for her outstanding accomplishments in the legal field. The prestigious award is given to a small group of "exceptional" women who are pioneers, educators, trailblazers, and role models. Dr. Jarrell will receive her award on October 28, 2015.As co-chair of Choat ...


20.10.2015

ProMetic''s PBI-4050 Granted Orphan Drug Designation for the Treatment of Idiopathic Pulmonary Fibrosis in Europe

LAVAL, QUEBEC -- (Marketwired) -- 10/13/15 -- ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF), ("ProMetic" or the "Corporation") announced today that an orphan drug designation status has been granted for its lead drug candidate, PBI-4050, for the treatment of idiopathic pulmonary fibrosis ("IPF"), by the European Commission.ProMetic is currently investigating the safety, tolerability and effects of PBI-4050 on pulmonary function, disease progression and inf ...


13.10.2015

ProMetic Reports Successful PBI-4050 Pre-IND Meeting with the US FDA for Idiopathic Pulmonary Fibrosis ("IPF")

LAVAL, QUEBEC -- (Marketwired) -- 10/01/15 -- ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF), ("ProMetic" or the "Corporation") announced today it had a successful Pre-Investigational New Drug ("Pre-IND") meeting with the US Food and Drug Administration ("FDA") for its orally active anti-fibrotic lead drug candidate, PBI-4050.The meeting with the FDA focused on ProMetic''s proposed clinical development program for PBI-4050 in patients wit ...


01.10.2015

Bridge Bank Launches Life Sciences Group

SAN JOSE, CA -- (Marketwired) -- 09/23/15 -- Bridge Bank announced today the launch of a new banking group -- Life Sciences Group (LSG) -- which will offer customized financial solutions to companies operating in the life sciences sector, including within the biotech, medical devices and pharma verticals. The Life Sciences Group will focus on providing term and revolving debt to life sciences companies for a variety of purposes including growth and working capital, refinancing, restructuring, r ...


23.09.2015

StockNewsNow.com Publishes New SNNLive Video Interview with Bellerophon Therapeutics, Inc.

LOS ANGELES, CA -- (Marketwired) -- 09/22/15 -- , The Official MicroCap News Source™, today published an SNNLive Video Interview with Jonathan Peacock, Chairman and CEO of Bellerophon Therapeutics, Inc. (NASDAQ: BLPH), a clinical-stage biotherapeutics company focused on developing therapies at the intersection of drugs and devices for the treatment of cardiopulmonary and cardiac diseases, according to the Company''s website (see here: ). The video interview was recorded on Tuesday, Se ...


22.09.2015

Choate, Hall & Stewart Named 2015 "Patent Strategy and Management Team of the Year" by LMG Life Sciences

BOSTON, MA -- (Marketwired) -- 09/17/15 -- announced today that the firm has been named the 2015 "Patent Strategy and Management Team of the Year" by LMG Life Sciences. The annual LMG Life Sciences awards recognize the leading attorneys, law firms, and in-house counsel teams that have played a significant role in the life sciences industry over the last 12 months. An awards ceremony was held on September 16, 2015 in New York City.Choate''s Life Sciences Group is internation ...


17.09.2015

StockNewsNow.com Publishes Q3 2015 Review SNNLive Video Interview With Pressure BioSciences, Inc.

LOS ANGELES, CA -- (Marketwired) -- 09/17/15 -- , The Official MicroCap News Source™, today published an SNNLive Video Interview with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO). PBI is a life sciences company that develops, markets, and sells proprietary laboratory instrumentation and associated consumables used in the critical process of preparing samples for analysis in the estimated $6B life sciences research market, according to the Company'� ...


17.09.2015

SHYFT Analytics Included as a Sample Vendor in Gartner''s Hype Cycle for Life Sciences

WALTHAM, MA -- (Marketwired) -- 09/09/15 -- , (Formerly Trinity Pharma Solutions), a leader in cloud-based data and guided analytics solutions for the global life sciences industry, today announced that it has been identified as a sample vendor in Gartner''s Hype Cycle for Life Sciences, 2015 report."Our technology integrates clinical and commercial data and translates it into enterprise-wide actionable insights and analytics to inform life science companies as they transform to ...


09.09.2015

ProMetic''s PBI-4050''s Positive Safety Review Triggers Expansion of Phase II Clinical Trial in Metabolic Syndrome Patients

LAVAL, QUEBEC -- (Marketwired) -- 08/27/15 -- ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF) ("ProMetic" or the "Corporation") reported today that its PBI-4050 has been confirmed to be safe and well tolerated in the first 12 metabolic syndrome with associated type 2 diabetes patients, following review of the safety data by the Data Safety Monitoring Board. ProMetic is now proceeding with the enrollment of an additional 24 patients, as planned in the study protocol des ...


27.08.2015

Dr. Stephen P. Spielberg Joins YourEncore''s Strategic Advisory Board and Regulatory Practice

INDIANAPOLIS, IN -- (Marketwired) -- 08/18/15 -- YourEncore (), a company that helps , and solve complex product development and regulatory challenges, announced the addition of Stephen P. Spielberg, M.D., Ph.D., to its Strategic Advisory Board and Regulatory Practice. . The comprises experts with deep experience running regulatory departments for the world''s largest pharmaceutical companies. In addition, experts include former senior Food & Drug Administration (FDA) official ...


18.08.2015

ProMetic Reports its Second Quarter 2015 Highlights and Financial Results

LAVAL, QUEBEC -- (Marketwired) -- 08/13/15 -- ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF) ("ProMetic" or the "Corporation") today reported its second quarter ended June 30, 2015 highlights and financial results."With our cash position combined with proceeds generated from our commercial activities, we are well positioned to execute on our development plans for our plasma-derived and small-molecule therapeutics", said Mr. Bruce Pritchard, Chief Operating a ...


13.08.2015

ProMetic Closes the Acquisition of Emergent BioSolutions'' Plasma Collection Center in Winnipeg, Canada

LAVAL, QUEBEC -- (Marketwired) -- 08/13/15 -- ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF) ("ProMetic" or the "Corporation") announced today that it has closed the acquisition of Emergent BioSolutions'' ("Emergent") plasma collection center located in Winnipeg, Canada following completion of closing conditions.The plasma collection center has now started to operate under ProMetic''s ownership following the grant and receipt of the regul ...


13.08.2015

ProMetic Successfully Completes First Dosing in Plasminogen Deficient Patients

LAVAL, QUEBEC -- (Marketwired) -- 08/10/15 -- ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF) ("ProMetic" or the "Corporation") reported today that is has successfully completed the first round of dosing of plasminogen deficient patients. ProMetic''s IV plasminogen was found to be safe, very well tolerated and there were no drug-related adverse events.The Phase I clinical trial is an open label, single ascending dose study that is investigating the safety, to ...


10.08.2015

ProMetic to Report its Second Quarter 2015 Financial Results and Hold Conference Call / Webcast

LAVAL, QUEBEC -- (Marketwired) -- 08/07/15 -- ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("ProMetic" or the "Corporation") today announced that it will report its financial results for the second quarter ended June 30, 2015 on Thursday August 13, 2015 after regular market hours.ProMetic will host a conference call at 11:00am (ET) on Friday August 14, 2015. The telephone numbers to access the conference call are 647-788-4922 (International) and 1-877-223-4471 (Nor ...


07.08.2015

StockNewsNow.com Publishes New SNNLive Video Interviews With Cesca Therapeutics, Inc.

LOS ANGELES, CA -- (Marketwired) -- 08/05/15 -- , The Official MicroCap News Source™, today published two SNNLive Video Interviews with Kenneth Harris, President, and Robin Stracey, Director and CEO of Cesca Therapeutics, Inc. (NASDAQ: KOOL), engaged in the research, development and commercialization of autologous cell-based therapeutics for use in regenerative medicine, according to the company''s website (see here: ). The video interview with Mr. Harris was recorded at the Marcum Mi ...


05.08.2015

European Commission Grants Orphan Drug Designation to ProMetic''s Plasma-Derived Plasminogen Drug

LAVAL, QUEBEC -- (Marketwired) -- 08/04/15 -- ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF), ("ProMetic" or the "Corporation") announced today that an orphan drug designation status has been granted for its human plasma derived plasminogen drug by the European Commission for the treatment of plasminogen deficiency.ProMetic is currently investigating the safety, tolerability and pharmacokinetics of its human plasma-derived plasminogen in patients suffering from plasmi ...


04.08.2015

StockNewsNow.com Publishes New SNNLive Video Interview With Provectus Biopharmaceuticals, Inc.

LOS ANGELES, CA -- (Marketwired) -- 07/28/15 -- , the Official MicroCap News Source, today published an SNNLive Video Interview with Peter R. Culpepper, CFO and COO of Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT), specializes in developing oncology and dermatology therapies, according to the company''s website (see here: ). The video interview was recorded at the Growth Capital Expo 2015 in Las Vegas, NV.Click the following link to watch the SNNLive Video Interview on StockNews ...


28.07.2015

YourEncore Adds Mike Lewis as Chief Sales & Marketing Officer

INDIANAPOLIS, IN -- (Marketwired) -- 07/09/15 -- YourEncore (), a company that helps firms in the , and industries solve complex innovation, compliance and productivity challenges, announced that Mike Lewis has joined the company as Chief Sales & Marketing Officer. .Lewis has a 20 year record of driving sales growth and providing award-winning sales leadership in professional services organizations.Lewis joins YourEncore from Navitas Life Sciences, where he was executive vice president, s ...


09.07.2015



All members: 9 436
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 282


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.